350 related articles for article (PubMed ID: 27956462)
21. Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T.
Aryal MP; Nagaraja TN; Keenan KA; Bagher-Ebadian H; Panda S; Brown SL; Cabral G; Fenstermacher JD; Ewing JR
Magn Reson Med; 2014 Jun; 71(6):2206-14. PubMed ID: 23878070
[TBL] [Abstract][Full Text] [Related]
22. Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.
Ningning D; Haopeng P; Xuefei D; Wenna C; Yan R; Jingsong W; Chengjun Y; Zhenwei Y; Xiaoyuan F
Neuroradiology; 2017 Jan; 59(1):51-59. PubMed ID: 27924360
[TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
Zhang W; Chen HJ; Wang ZJ; Huang W; Zhang LJ
Eur Radiol; 2017 May; 27(5):2086-2094. PubMed ID: 27488851
[TBL] [Abstract][Full Text] [Related]
24. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume.
Taoka T; Kawai H; Nakane T; Hori S; Ochi T; Miyasaka T; Sakamoto M; Kichikawa K; Naganawa S
Magn Reson Imaging; 2016 Sep; 34(7):896-901. PubMed ID: 27109485
[TBL] [Abstract][Full Text] [Related]
25. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
26. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.
Zhang Y; Wang F; Huang Y
Clinics (Sao Paulo); 2024; 79():100367. PubMed ID: 38692010
[TBL] [Abstract][Full Text] [Related]
27. Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI.
Jones KM; Pagel MD; Cárdenas-Rodríguez J
Magn Reson Imaging; 2018 Apr; 47():16-24. PubMed ID: 29155024
[TBL] [Abstract][Full Text] [Related]
28. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
29. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
Boult JK; Borri M; Jury A; Popov S; Box G; Perryman L; Eccles SA; Jones C; Robinson SP
NMR Biomed; 2016 Nov; 29(11):1608-1617. PubMed ID: 27671990
[TBL] [Abstract][Full Text] [Related]
30. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal evaluation of tumor microenvironment in rat focal brainstem glioma using diffusion and perfusion MRI.
Magdoom KN; Delgado F; Bohórquez AC; Brown AC; Carney PR; Rinaldi C; Mareci TH; Ewing JR; Sarntinoranont M
J Magn Reson Imaging; 2019 May; 49(5):1322-1332. PubMed ID: 30318760
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
[TBL] [Abstract][Full Text] [Related]
33. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
34. Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrast-enhanced synchrotron radiation CT.
Balvay D; Troprès I; Billet R; Joubert A; Péoc'h M; Cuenod CA; Le Duc G
Radiology; 2009 Mar; 250(3):692-702. PubMed ID: 19095783
[TBL] [Abstract][Full Text] [Related]
35. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
[TBL] [Abstract][Full Text] [Related]
36. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance dispersion imaging for localization of angiogenesis and cancer growth.
Mischi M; Turco S; Lavini C; Kompatsiari K; de la Rosette JJ; Breeuwer M; Wijkstra H
Invest Radiol; 2014 Aug; 49(8):561-9. PubMed ID: 24691142
[TBL] [Abstract][Full Text] [Related]
38. Preoperative vascular heterogeneity and aggressiveness assessment of pituitary macroadenoma based on dynamic contrast-enhanced MRI texture analysis.
Liu YQ; Gao BB; Dong B; Padikkalakandy Cheriyath SS; Song QW; Xu B; Wei Q; Xie LZ; Guo Y; Miao YW
Eur J Radiol; 2020 Aug; 129():109125. PubMed ID: 32593076
[TBL] [Abstract][Full Text] [Related]
39. Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function.
Filice S; Crisi G
J Neuroimaging; 2016; 26(1):124-9. PubMed ID: 25923172
[TBL] [Abstract][Full Text] [Related]
40. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
